Ackman is 'profoundly' sorry for US$4b Valeant 'mistake'
New York
BILL Ackman "deeply and profoundly" apologised for his investment in Valeant Pharmaceuticals International Inc, a "huge mistake" that cost his firm US$4 billion.
In his annual letter to investors in his publicly traded fund Pershing Square Holdings Ltd, Mr Ackman in part blamed Valeant's overpaying for Salix Pharmaceuticals in 2015 for the drugmaker's downfall. But he also took blame for misjudging the company's management and its aggressive strategy.
TRENDING NOW
When every phone becomes a satellite phone, what happens to Asia’s telcos?
Koh Brothers Eco Engineering faces up to S$57.6 million in potential legal liabilities
Father-and-son duo Raj Kumar and Kishin in exclusive due diligence to buy Scotts Square
Anytime Fitness Asia’s owner said to weigh US$400 million sale